What Is SIBO and Why Women Over 40 Are More Susceptible

Bloating, gas, abdominal discomfort, and unpredictable bowel habits are among the most common digestive complaints women experience after 40, and one of the most frequently overlooked causes is SIBO: small intestinal bacterial overgrowth. Unlike conditions that affect the large intestine (where most gut bacteria should live), SIBO occurs when bacteria migrate into or multiply excessively in the small intestine, where they interfere with digestion, ferment carbohydrates prematurely, and create the gas and bloating that so many women find disruptive and confusing. The fact that SIBO symptoms overlap significantly with IBS means it is routinely misdiagnosed or left unaddressed for years. Understanding what SIBO is, why women over 40 are more susceptible, and how it is identified and addressed can be genuinely life-changing for women who have struggled with unexplained digestive symptoms.

What Is SIBO?

The small intestine is the section of the digestive tract between the stomach and large intestine (colon). It is approximately six meters long and is where most nutrient digestion and absorption occurs. Under normal conditions, the small intestine contains relatively few bacteria, typically fewer than 10,000 organisms per milliliter, because stomach acid, bile, and the migrating motor complex (a wave-like cleaning motion that sweeps the gut every 90 minutes when fasting) keep bacterial populations controlled.

SIBO occurs when bacterial populations in the small intestine exceed 10^5-10^6 organisms per milliliter, a 10-100 fold increase. These bacteria, typically species from the large intestine (Escherichia coli, Klebsiella, Bacteroides, and methane-producing archaea like Methanobrevibacter smithii), begin to ferment carbohydrates in the small intestine that would normally pass through to the colon before fermentation.

This premature fermentation produces large amounts of hydrogen gas (in hydrogen-dominant SIBO) or methane (in methane-dominant SIBO, now sometimes called IMO: intestinal methanogen overgrowth). These gases cause the classic presentation: bloating that starts within 30-90 minutes of eating, distension, excess flatulence, and abdominal cramping.

The fermentation also impairs the digestion and absorption of fats, carbohydrates, and key nutrients. In chronic or severe SIBO, this leads to deficiencies in fat-soluble vitamins (A, D, E, K), vitamin B12, and iron, contributing to fatigue and systemic symptoms that extend well beyond digestive discomfort.

Why Women Over 40 Are More Susceptible

Declining stomach acid (hypochlorhydria). Stomach acid is the first line of defense against bacterial overgrowth in the upper GI tract: it sterilizes food and prevents colonization of the small intestine. After 40, stomach acid production commonly declines, particularly in women under high chronic stress (cortisol suppresses stomach acid secretion) or those taking proton pump inhibitors (PPIs) for reflux. Low stomach acid allows bacteria to survive in areas they would not otherwise reach.

Slowed gut motility after menopause. The migrating motor complex (MMC), which clears bacteria from the small intestine during fasting periods, depends partly on the hormone motilin and is affected by estrogen levels. After menopause, the MMC’s cleansing waves may become less frequent and less powerful, allowing bacterial populations in the small intestine to build up between meals.

Stress and the HPA axis. Chronic stress reduces gut motility through the sympathetic nervous system (“fight-or-flight” response slows digestion) and impairs the secretory IgA component of intestinal immune function, which normally helps keep bacterial populations in check. Women in perimenopause managing high stress loads are at double risk from the combination of motility impairment and reduced intestinal immunity.

History of antibiotics or gut infections. Any event that disrupts the normal gut microbiome architecture (a course of antibiotics, traveler’s diarrhea, food poisoning, or prolonged use of PPIs) can allow overgrowth to establish itself in the small intestine. The cumulative history of antibiotic use over decades is a significant SIBO risk factor by midlife.

Diagnosing SIBO: What to Expect

SIBO is diagnosed with a glucose or lactulose breath test, a non-invasive test that measures the hydrogen and methane gases produced by gut bacteria after you consume a specific sugar solution.

In a hydrogen-positive test, breath hydrogen rises by 20 ppm or more above baseline within the first 90 minutes (for glucose) or before 120 minutes (for lactulose), indicating bacterial fermentation in the small intestine rather than the colon. A methane rise of 10 ppm or more at any point is considered positive for IMO.

The test is widely available through gastroenterology clinics and functional medicine practitioners. It can be done at home with a test kit sent to a laboratory. While not perfect (some practitioners debate the optimal cutoff values and substrates), the breath test is the most practical and accessible diagnostic tool available outside of direct jejunal aspirate culture (a procedure requiring endoscopy).

A clinical assessment alongside the breath test, considering history, symptoms, diet, and predisposing factors, is important for interpreting results correctly.

Treatment and Prevention

The primary treatment for SIBO is antimicrobial therapy, which may be prescription antibiotics (rifaximin is most commonly used for hydrogen-dominant SIBO) or herbal antimicrobials (a combination of oregano oil, berberine, neem, or allicin from garlic). A 2014 study in Global Advances in Health and Medicine found herbal antimicrobials to be as effective as rifaximin for normalizing SIBO breath test results.

Dietary approaches during treatment often involve a low-FODMAP diet (reducing fermentable carbohydrates that feed the bacteria) or a specific carbohydrate diet (SCD) to reduce the fermentation substrate available during treatment. These diets are not permanent solutions but can significantly reduce symptoms during the antimicrobial phase.

Preventing recurrence requires addressing the root cause: increasing stomach acid (digestive bitters, apple cider vinegar, or HCl with pepsin under practitioner guidance), supporting gut motility (prokinetics like ginger, 5-HTP, or prescription low-dose naltrexone), managing chronic stress, and using targeted probiotic support after treatment to restore healthy bacterial balance in the colon.

Prokinetic supplementation between meals, when the MMC is most active, is particularly important for women whose SIBO was driven by motility impairment.

Frequently Asked Questions

What are the most common SIBO symptoms?

The classic symptoms are bloating and distension that appear 30-90 minutes after eating, excess gas (particularly after starchy or sugary foods), abdominal cramping, and altered bowel habits (diarrhea, constipation, or alternating). Fatigue, brain fog, and nutritional deficiencies can also occur in chronic cases.

How is SIBO diagnosed?

The most practical diagnostic tool is the hydrogen-methane breath test, available through gastroenterology clinics and some functional medicine practitioners. It involves drinking a glucose or lactulose solution and measuring the gases breathed out over 2-3 hours. Elevated hydrogen or methane gas in the breath during the small intestinal transit window indicates SIBO.

Can SIBO cause fatigue and brain fog?

Yes. SIBO impairs absorption of iron, B12, and fat-soluble vitamins, all of which contribute to fatigue. The systemic inflammatory response to bacterial overgrowth, including elevated lipopolysaccharides (LPS) in the bloodstream, is associated with cognitive symptoms including brain fog and difficulty concentrating.

Does SIBO go away on its own?

Mild SIBO may improve with dietary changes and motility support, but established SIBO typically requires antimicrobial treatment to substantially reduce bacterial populations. Without addressing predisposing factors (low acid, slow motility, stress), SIBO tends to recur even after successful treatment.

What probiotic is best after SIBO treatment?

After antimicrobial treatment, Lactobacillus and Bifidobacterium strains used in typical probiotic supplements are generally appropriate, as SIBO bacteria are gram-negative and unaffected by these species. Some practitioners start probiotics during treatment specifically to support colonic microbiome health. Saccharomyces boulardii (a beneficial yeast) is often recommended during antibiotic treatment to prevent dysbiosis in the colon.

The Gut-Brain-Hormone Connection: How SIBO Affects More Than Digestion

SIBO’s impact on women’s health extends well beyond the bloating and bowel irregularity that are its most recognized symptoms. The bacterial overgrowth in the small intestine creates a cascade of systemic effects through several mechanisms that are particularly relevant to the hormonal and neurological challenges women face after 40.

Estrogen recirculation and SIBO. The gut microbiome plays a direct role in estrogen metabolism through a collection of bacterial enzymes collectively called the estrobolome. These enzymes, primarily beta-glucuronidase-producing species, deconjugate estrogen metabolites that the liver has prepared for excretion, reactivating them for reabsorption into circulation. In women with SIBO, the dysbiotic bacterial overgrowth in the small intestine can produce excess beta-glucuronidase activity, leading to estrogen recirculation and elevated free estrogen levels. This contributes to estrogen-dominant symptoms: heavier periods, breast tenderness, mood fluctuations, and weight gain around the hips and thighs that may appear to be purely hormonal in origin but have a gut component.

Nutrient deficiencies and hormonal consequences. SIBO bacteria compete with the host for vitamin B12 and fat-soluble vitamins, and they produce metabolites that interfere with iron absorption. B12 deficiency produces fatigue, memory problems, and mood disturbance that can be mistaken for perimenopause-related symptoms. Iron deficiency from impaired absorption compounds the fatigue picture and can contribute to hair loss, cold intolerance, and reduced exercise capacity. Women who are experiencing perimenopausal symptoms alongside significant fatigue should have SIBO considered in the diagnostic picture if digestive symptoms are also present.

Gut-brain axis effects. The bacterial overgrowth in SIBO produces lipopolysaccharides (LPS), components of bacterial cell walls that cross a compromised intestinal barrier and enter systemic circulation. LPS triggers a low-grade systemic inflammatory response that activates the vagus nerve and affects neurotransmitter production in the gut-brain axis. This mechanism is specifically associated with anxiety, depression, and cognitive symptoms that overlap substantially with the mood and brain changes of perimenopause. Many women in perimenopause may be experiencing SIBO-driven neuroinflammation amplifying symptoms that are commonly attributed entirely to hormonal change.

Treating SIBO in women over 40 who have both digestive and systemic symptoms can therefore produce improvements that extend well beyond the gut, including clearer cognition, more stable mood, better energy, and improved hormonal balance, making it worth investigating for any woman whose perimenopausal symptom picture does not fully respond to hormone-focused interventions alone.

References

1. Ghoshal UC, et al. “Small intestinal bacterial overgrowth and irritable bowel syndrome: a bridge between functional organic dichotomy.” Gut Liver. 2017;11(2):196-208. doi: 10.5009/gnl16126
2. Bures J, et al. “Small intestinal bacterial overgrowth syndrome.” World J Gastroenterol. 2010;16(24):2978-2990. PMID: 20572300
3. Pimentel M, et al. “Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome.” Am J Gastroenterol. 2000;95(12):3503-3506. PMID: 11151884
4. Chedid V, et al. “Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth.” Glob Adv Health Med. 2014;3(3):16-24. doi: 10.7453/gahmj.2014.019
5. Quigley EM, Quera R. “Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics.” Gastroenterology. 2006;130(2 Suppl 1):S78-90. PMID: 16473077